Mar 12, 2019 / 01:20PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Okay. Well, good morning, everybody, and welcome to the second day of the 39th Annual Cowen Healthcare Conference here in Boston. It's a great pleasure to introduce David Meline, Executive Vice President and Chief Financial Officer at Amgen and Arvind Sood, Vice President of Investor Relations. I think David is going to kick it off with a few slides and then we'll open a fireside chat. You're welcome.
David W. Meline - Amgen Inc. - Executive VP & CFO
Okay, good morning. Okay, just to frame the opportunity for you as investors. If you look at the company over the last 5 years, we set out a plan for the company to transform the business. We had a number of objectives strategically as well as financially, and we are pleased to announce at year-end that we met or exceeded all of those objectives for the company. I think importantly then looking forward, we feel very good about the prospects for continued long-term growth for the company, and that's really
Amgen Inc at Cowen Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot